Hall Ashley Insider Trades

Insider Trading History

Track insider trading activity for Hall Ashley. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Structure Therapeutics
Structure Therapeutics GPCR
Chief Development Officer
Holding Value $5.82M 155,187 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.39M 106,779 shares
$50.46
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
Chief Development Officer
Holding Value $4.03M 107,481 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$305k 4,836 shares
$63.04
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
Chief Development Officer
Holding Value $17.3k 462 shares
Last Trade
Nov 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.14k 237 shares
$34.34
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
Chief Development Officer
Holding Value $4.21M 112,317 shares
Last Trade
Sep 18, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$140k 6,021 shares
$23.23
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
Chief Development Officer
Holding Value $8.44k 225 shares
Last Trade
May 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.55k 225 shares
$24.67
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
Chief Development Officer
Holding Value $4.65M 124,032 shares
Last Trade
Mar 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.61M 124,032 shares
$21.05
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
Chief Development Officer
Holding Value $3.11M 82,890 shares
Last Trade
Sep 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.17M 82,890 shares
$38.26
$37.50
Reneo Pharmaceuticals
Reneo Pharmaceuticals RPHM
Chief Development Officer
Holding Value $1.99M 109,375 shares
Last Trade
Aug 28, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$944k 15,625 shares
$60.40
$18.20
Reneo Pharmaceuticals
Reneo Pharmaceuticals RPHM
Chief Development Officer
Holding Value $721k 39,600 shares
Last Trade
Aug 28, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$944k 15,625 shares
$60.40
$18.20
Reneo Pharmaceuticals
Reneo Pharmaceuticals RPHM
Chief Development Officer
Holding Value $1.01M 55,225 shares
Last Trade
Aug 28, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$944k 15,625 shares
$60.40
$18.20
Reneo Pharmaceuticals
Reneo Pharmaceuticals RPHM
Chief Development Officer
Holding Value $2.28M 125,000 shares
Last Trade
Dec 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.25M 125,000 shares
$18.00
$18.20
Reneo Pharmaceuticals
Reneo Pharmaceuticals RPHM
Chief Development Officer
Holding Value $3.28M 180,000 shares
Last Trade
Nov 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.9M 180,000 shares
$88.50
$18.20
Esperion Therapeutics
Esperion Therapeutics ESPR
Chief Development Officer
Holding Value $97.3k 31,000 shares
Last Trade
Jan 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 38,000 shares
$32.12
$3.14
Esperion Therapeutics
Esperion Therapeutics ESPR
Chief Development Officer
Holding Value $31.4k 10,000 shares
Last Trade
Feb 26, 2020 Sale
$20.9M 365,750 shares
$57.05
$3.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up